{
  "id": 4061456,
  "title": "10x Genomics CEO Serge Saxonov sells $667,900 in stock",
  "url": "https://urgent.news/2026/08/29/10x-genomics-ceo-serge-saxonov-sells-667-900-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-29T00:01:03.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/10x-genomics-ceo-serge-saxonov-sells-667900-in-stock-93CH-4881888"
  },
  "original_language": "en",
  "account": "Serge Saxonov, CEO of 10x Genomics, sold 10,486 shares of Class A Common Stock on August 26, 2026. The sales, conducted under a pre-approved Rule 10b5-1 trading plan, totaled around $667,900, with shares traded at prices between $63.0229 and $64.7465 per share. This move occurred as TXG shares hovered near their 52-week high of $66.94, following a 339% increase over the past year. InvestingPro analysts currently deem the stock overvalued, suggesting a 12 ProTips for subscribers. Post-transactions, Saxonov retains 1,075,349 shares Class A Common Stock, along with indirect ownership through various trusts. Meanwhile, 10x Genomics reported stronger-than-expected Q2 2026 results, generating $151.04 million in revenue, and an adjusted loss of $0.14 per share, surpassing analysts' forecasts. Despite the positive financial outlook, the company's stock saw a decline post-announcement, attributed to investor concerns about near-term performance and the platform transition. Notably, Canaccord raised its price target from $50 to $60, affirming a Buy rating and indicating a 15% upside potential, driven by medium- to long-term revenue and margin expectations in AI and biopharma sectors.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Asana CEO Daniel Rogers sells $16,550 in company stock",
        "url": "https://urgent.news/2026/08/28/asana-ceo-daniel-rogers-sells-16-550-in-company-stock",
        "published": "2026-08-28T22:32:42.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}